Deploying DeepSeek 175B Locally on a Single Consumer-Grade RTX 4060 Laptop with 32GB RAM for 200k-Scale Protein-Ligand Virtual Screening
2026-08-31 • Machine Learning
Machine Learning
AI summaryⓘ
The authors show that a very large language model, DeepSeek 175B, usually requiring expensive supercomputers, can run on a regular gaming laptop with moderate memory. They used this setup to predict how well different drugs might bind to proteins for 20 targets, doing 200,000 screens in about 3 days. Their method was 100 times faster than a typical powerful GPU cluster and kept prediction errors within an acceptable range for early drug research. They also found most of the computation time was used managing memory, not the model itself. This proves you don't always need massive hardware for big AI tasks in drug discovery.
large language modelprotein-ligand interactionvirtual screeningDeepSeek 175BGPUbinding affinitydrug discoverymemory managementmodel optimizationconsumer-grade hardware
Authors
Rui Xiao, Yili Xu
Abstract
Recent advances in large language models (LLMs) have demonstrated exceptional performance in protein-ligand interaction prediction, but state-of-the-art pipelines for large-scale virtual screening almost exclusively rely on high-end GPU clusters with hundreds of gigabytes of memory, creating prohibitive hardware barriers for small academic teams. In this work, we present a fully local low-resource framework that deploys the 175-billion-parameter DeepSeek 175B LLM on a single consumer-grade RTX 4060 laptop equipped with 32GB system RAM and 8GB VRAM, completing a full 200k-scale protein-ligand virtual screening workflow across 20 distinct protein targets. Our implementation achieves 100x throughput of an 8-card A100 cluster baseline under identical task configurations within 72 hours, with an average binding affinity prediction error of 0.88 kcal/mol across all targets, satisfying the 1.0 kcal/mol chemical accuracy requirement for preclinical drug discovery. Systematic runtime profiling reveals that heterogeneous memory management overhead accounts for 72% of total execution time, while accuracy loss introduced by model optimization contributes less than 10% to total prediction error. This work validates the engineering feasibility of running industrial-scale trillion-parameter LLM-driven biomedical computing tasks on consumer hardware, establishing a new low-barrier paradigm for AI-powered early stage drug discovery.